Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New anticancer agents.
Weiss GR, Burris 3rd HA, Eckardt JR, Eckhardt SG, Fields SM, O'Rourke T, Rodriguez GI, Rothenberg ML, Valley AJ. Weiss GR, et al. Among authors: eckardt jr. Cancer Chemother Biol Response Modif. 1996;16:132-67. Cancer Chemother Biol Response Modif. 1996. PMID: 8639381 Review. No abstract available.
New anticancer agents.
Brown TD, Burris HA, Eckardt JR, O'Rourke TJ, Rodriguez GI, Wall JG, Weiss GR. Brown TD, et al. Among authors: eckardt jr. Cancer Chemother Biol Response Modif. 1992;13:115-55. Cancer Chemother Biol Response Modif. 1992. PMID: 1389907 Review. No abstract available.
New anticancer agents.
Weiss GR, Burris HA 3rd, Eckardt JR, Fields S, O'Rourke T, Rodriguez GI, Rothenberg ML. Weiss GR, et al. Among authors: eckardt jr. Cancer Chemother Biol Response Modif. 1994;15:130-51. Cancer Chemother Biol Response Modif. 1994. PMID: 7779583 Review. No abstract available.
New anticancer agents.
Weiss GR, Burris HA, Eckardt JR, Fields S, Johnson R, O'Rourke T, Rodriguez GI, Rothenberg ML, Wall J. Weiss GR, et al. Among authors: eckardt jr. Cancer Chemother Biol Response Modif. 1993;14:118-28. Cancer Chemother Biol Response Modif. 1993. PMID: 8312101 Review. No abstract available.
Preclinical and phase I trials of topoisomerase I inhibitors.
Von Hoff DD, Burris HA 3rd, Eckardt J, Rothenberg M, Fields SM, Chen SF, Kuhn JG. Von Hoff DD, et al. Cancer Chemother Pharmacol. 1994;34 Suppl:S41-5. doi: 10.1007/BF00684862. Cancer Chemother Pharmacol. 1994. PMID: 8070026 Clinical Trial.
A phase I clinical and pharmacokinetic study of the angiogenesis inhibitor, tecogalan sodium.
Eckhardt SG, Burris HA, Eckardt JR, Weiss G, Rodriguez G, Rothenberg M, Rinaldi D, Barrington R, Kuhn JG, Masuo K, Sudo K, Atsumi R, Oguma T, Higashi L, Fields S, Smetzer L, Von Hoff DD. Eckhardt SG, et al. Among authors: eckardt jr. Ann Oncol. 1996 Jul;7(5):491-6. doi: 10.1093/oxfordjournals.annonc.a010638. Ann Oncol. 1996. PMID: 8839904 Free article. Clinical Trial.
66 results